BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 3011235)

  • 1. The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
    Baskett TF; Parsons ML; Peddle LJ
    CMAJ; 1986 Jun; 134(11):1259-61. PubMed ID: 3011235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Rh alloimmunization.
    Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
    J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antenatal suppression of Rh alloimmunization.
    Bowman JM
    Clin Obstet Gynecol; 1991 Jun; 34(2):296-303. PubMed ID: 1651184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures.
    Bowman JM; Pollock JM
    Transfus Med Rev; 1987 Aug; 1(2):101-12. PubMed ID: 2856541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of Rh alloimmunization. Fact or fancy?
    Bowman JM; Pollock JM
    Vox Sang; 1984; 47(3):209-15. PubMed ID: 6087562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of severe alloimmunization.
    Bennebroek Gravenhorst J
    Vox Sang; 1994; 67 Suppl 3():235-8. PubMed ID: 7975499
    [No Abstract]   [Full Text] [Related]  

  • 7. Compliance with postpartum Rh isoimmunization prophylaxis in Alberta.
    Huchcroft S; Gunton P; Bowen T
    CMAJ; 1985 Nov; 133(9):871-5. PubMed ID: 2996738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oliver memorial lecture. Towards the conquest of Rh haemolytic disease: Britain's contribution and the role of serendipity.
    Tovey LA
    Transfus Med; 1992 Jun; 2(2):99-109. PubMed ID: 1339195
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of Rh immune globulin: a review.
    Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
    Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
    [No Abstract]   [Full Text] [Related]  

  • 10. Rh(O)D immune globulin products for prevention of alloimmunization during pregnancy.
    Aitken SL; Tichy EM
    Am J Health Syst Pharm; 2015 Feb; 72(4):267-76. PubMed ID: 25631833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
    Vŭlcheva B; Spasova K
    Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of rhesus alloimmunization in pregnancy.
    Moise KJ
    Obstet Gynecol; 2008 Jul; 112(1):164-76. PubMed ID: 18591322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastosis fetalis?
    Chitkara U; Bussel J; Alvarez M; Lynch L; Meisel RL; Berkowitz RL
    Obstet Gynecol; 1990 Oct; 76(4):703-8. PubMed ID: 2120641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A
    Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
    [No Abstract]   [Full Text] [Related]  

  • 15. Rh immune globulin after genetic amniocentesis: impact on pregnancy outcome.
    Crane JP; Rohland B; Larson D
    Am J Med Genet; 1984 Dec; 19(4):763-8. PubMed ID: 6097129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 18. RhD hemolytic disease of the newborn.
    Bowman JM
    N Engl J Med; 1998 Dec; 339(24):1775-7. PubMed ID: 9845715
    [No Abstract]   [Full Text] [Related]  

  • 19. Rh(D) haemolytic disease of the newborn: the changing scene.
    Urbaniak SJ
    Br Med J (Clin Res Ed); 1985 Jul; 291(6487):4-6. PubMed ID: 2990630
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of Rh(D) alloimmunization: a cost-benefit analysis.
    Baskett TF; Parsons ML
    CMAJ; 1990 Feb; 142(4):337-9. PubMed ID: 2154307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.